The company expired is plan on April 24, 2024.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
47.22 EUR | +2.65% |
|
-11.31% | -19.82% |
25/06 | Market Update-Europe closes lower in a session marked by a wait-and-see attitude | RE |
25/06 | EUROFINS : Oddo BHF confirms its recommendation on the stock | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.82% | 949.52Cr | |
+24.80% | 8.92TCr | |
-24.27% | 7.59TCr | |
+2.32% | 2.74TCr | |
-10.62% | 1.75TCr | |
-0.04% | 1.7TCr | |
-0.23% | 1.54TCr | |
+79.10% | 1.37TCr | |
+78.10% | 1.32TCr | |
-25.61% | 1.28TCr |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired.